Ушбу иш иқтибос қилган ишлар

16 та иш

Иш: A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

1. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

   Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane +15

   Мақола20207 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006850

2. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

   Andrew Nunn, Patrick Phillips, Sarah Meredith +16

   Мақола20196 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006848

3. Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

   Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se +25

   Мақола20226 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006859

4. Principles for designing future regimens for multidrug-resistant tuberculosis

   Grania Brigden, Bern-Thomas Nyang’wa, Philipp du Cros +9

   Мақола20133 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006845

5. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

   Шарҳ мақола20203 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006851

6. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review

   Tadayuki Tanimura, Ernesto Jaramillo, Diana Weil +2

   Шарҳ мақола20142 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006844

7. Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis

   Ilse Tack, Asnake Yohannes Dumicho, Liesbet Ohler +6

   Мақола20202 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006854

8. Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO

   Beverley Stringer, Karen Lowton, Nicola James +1

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006857

9. Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial

   Bern-Thomas Nyang’wa, Frank Kloprogge, David Moore +4

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.006858

10. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.006846

11. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.006847

12. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.006849

13. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.006852

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.006853

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.006855

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.006856